MTOR and asthma: If validated in human studies, targeting the DC-NK cell metabolic checkpoint with agents that restore autophagic plasticity, rebalance AMPK/mTOR signaling, or normalize airway nutrient and pH landscapes may represent a promising strategy to prevent viral-triggered asthma exacerbations.